AI Article Synopsis
- - The study explores the role of phospholipids in the intestinal mucus barrier, particularly in patients with inflammatory bowel diseases (IBD) like ulcerative colitis (UC) and Crohn's disease (CD).
- - Researchers collected mucus samples from 21 UC patients, 10 CD patients, and 29 healthy controls, using advanced mass spectrometry to analyze specific phospholipids, finding that UC patients had significantly lower concentrations of phosphatidylcholine (PC) in their mucus.
- - The findings suggest that changes in phospholipid composition and concentration in the intestinal mucus of UC patients may contribute to disease development, indicating potential avenues for new treatments.
Article Abstract
Background: Phospholipids are essential for the normal function of the intestinal mucus barrier. The objective of this study was to systematically investigate phospholipids in the intestinal mucus of humans suffering from inflammatory bowel diseases, where a barrier defect is strongly supposed to be pathogenetic.
Methods: Optimal mucus recovery was first validated in healthy mice and the method was then transferred to the endoscopic acquisition of ileal and colonic mucus from 21 patients with ulcerative colitis (UC), 10 patients with Crohn's disease (CD), and 29 healthy controls. Nano-electrospray ionization tandem mass spectrometry (ESI-MS/MS) was used to determine phosphatidylcholine (PC), lysophosphatidylcholine (LPC), and sphingomyelin (SM) in lipid extracts of mucus specimens.
Results: Human and rodent mucus contained very similar phospholipid species. In the ileal and colonic mucus from patients suffering from UC, the concentration of PC was highly significantly lower (607 +/- 147 pmol/100 microg protein and 745 +/- 148 pmol/100 microg protein) compared to that of patients with CD (3223 +/- 1519 pmol/100 microg protein and 2450 +/- 431 pmol/100 microg protein) and to controls (3870 +/- 760 pmol/100 microg protein and 2790 +/- 354 pmol/100 microg protein); overall, P = 0.0002 for ileal specimens and P < 0.0001 for colonic specimens. Independent of disease activity, patients suffering from UC showed an increased saturation grade of PC fatty acid residues and a higher LPC-to-PC ratio.
Conclusions: The intestinal mucus barrier of patients with UC is significantly altered concerning its phospholipid concentration and species composition. These alterations may be very important for the pathogenesis of this disease and underline new therapeutic strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ibd.20993 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
Inflamm Bowel Dis
November 2009
Department of Gastroenterology, University Hospital Heidelberg, Heidelberg, Germany.
Article Synopsis
- - The study explores the role of phospholipids in the intestinal mucus barrier, particularly in patients with inflammatory bowel diseases (IBD) like ulcerative colitis (UC) and Crohn's disease (CD).
- - Researchers collected mucus samples from 21 UC patients, 10 CD patients, and 29 healthy controls, using advanced mass spectrometry to analyze specific phospholipids, finding that UC patients had significantly lower concentrations of phosphatidylcholine (PC) in their mucus.
- - The findings suggest that changes in phospholipid composition and concentration in the intestinal mucus of UC patients may contribute to disease development, indicating potential avenues for new treatments.
An optimized assay for transcription factor NF-kappaB with dsDNA-coupled microplate.
Colloids Surf B Biointerfaces
March 2007
State Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, China.
To develop an EMSA-free assay approach for analyzing the sequence-specific DNA-binding proteins (DBPs), an easy cost-effective dsDNA-coupled plate (dcPlate) was developed in our lab for this purpose. In this paper, the assay conditions of such dcPlate were fully optimized for detecting an important transcription factor, NF-kappaB. The optimized parameters of dcPlate for assay of NF-kappaB were as follows: immobilized DNA probe at the concentration of 25 pmol/100 microL-well, incubation time of 90 min for NF-kappaB binding to dcPlate, primary and secondary antibody concentration of 0.
View Article and Find Full Text PDFCarotid chemoreceptor reflex modulation by arginine-vasopressin microinjected into the nucleus tractus solitarius in rats.
Arch Med Res
August 2006
University Center for Biomedical Research (CUIB), University of Colima, Colima, Mexico.
Background: In addition to their role of sensing O2, pH, CO2, osmolarity and temperature, carotid body receptors (CBR) were proposed by us and others to have a glucose-sensing role in the blood entering the brain, integrating information about blood glucose and O2 levels essential for central nervous system (CNS) metabolism. The nucleus tractus solitarius (NTS) is an important relay station in central metabolic control and receives signals from peripheral glucose-sensitive hepatoportal afferences, from central glucose-responsive neurons in the brainstem and from CBR and arginine-vasopressin (AVP)-containing axons from hypothalamic nuclei.
Methods: In normal Wistar rats anesthetized with pentobarbital, permanent cannulas were placed stereotaxically in the NTS.
Nitric oxide modulation of glutamatergic, baroreflex, and cardiopulmonary transmission in the nucleus of the solitary tract.
Am J Physiol Heart Circ Physiol
January 2005
Department of Physiology, Universidade Federal de São Paulo-Escola Paulista de Medicina, Brazil.
The neuromodulatory effect of NO on glutamatergic transmission has been studied in several brain areas. Our previous single-cell studies suggested that NO facilitates glutamatergic transmission in the nucleus of the solitary tract (NTS). In this study, we examined the effect of the nitric oxide synthase (NOS) inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) on glutamatergic and reflex transmission in the NTS.
View Article and Find Full Text PDFCharacterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).
Hypertension
March 2003
Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil.
Angiotensin-(1-7) [Ang-(1-7)] has biological actions that can often be distinguished from those of angiotensin II (Ang II). Recent studies indicate that the effects of Ang-(1-7) are mediated by specific receptor(s). We now report the partial characterization of a new antagonist selective for Ang-(1-7), D-Pro7-Ang-(1-7).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!